COVID-19: Прививки
Назад
17-Year-Old Develops Multisystem Inflammatory Syndrome and Myocarditis After Pfizer Vaccine
A peer-reviewed brief report published Oct. 7 in Acta Paedatrica
describes a case of multisystem inflammatory syndrome in a previously
healthy 17-year-old male who developed fever, vomiting, myalgia and
chest pain five days after his second dose of the Pfizer-BioNTech
vaccine.
The patient developed myocarditis — inflammation that results from the body’s immune reaction to initial heart damage — with a severely reduced ejection fraction of 20%. He was then placed in the ICU for six days with norepinephrine infusion, high-flow oxygen therapy, steroids, intravenous immunoglobulin and antibiotics. He was discharged after 10 days of hospitalization. “To our knowledge, this is the first reported case of an adolescent who developed fever and multisystem inflammation following an mRNA SARS-CoV-2 vaccination,” the authors said.
